Warrior, S., Jaber, D. A., Heater, N. K., Marini, S., Ma, Y., Sun, Z., Liu, H., Zhang, Q., Zhang, Y., Cristofanilli, M., Gradishar, W. J., Lu, J. M. (2025). The use of circulating tumor DNA (ctDNA) to evaluate need for additional targeted therapies in HER2 positive metastatic breast cancer (MBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13003